TPI Reports Second Quarter Fiscal Year 2013 Financial Results

Published: Feb 14, 2013

CHENGDU, China, Feb. 14, 2013 -- /PRNewswire/ -- Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) announced financial results for second quarter of the fiscal year 2013.

Back to news